Home | Contact | Sitemap | Restricted area
Phase II - III
Iris Pharma is a leading, therapeutically specialized Contract Research Organization (CRO) focused on ophthalmology clinical trials.
Iris Pharma has managed partial or full-service phase II and phase III clinical trials in many eye disorders.
We maintain a network of highly motivated investigators for clinical research throughout Austria, Belgium, Denmark, Eastern Europe (Bulgaria, Czech Republic, Poland, Romania), Eire, France, Germany, India, Israel, Italy, Morocco, North America (USA, Canada), Portugal, Saudi Arabia, Spain, Switzerland, The Nertherlands, Tunisia, Turkey and the United Kingdom.
Iris Pharma's experience in the field of ophthalmology enables us to conduct phase 2 and phase 3 clinical trials which required specific knowledge, for exemple analysis of visual field or evaluation of inflammation by laser flare meter.
Fields of expertise

Copyright 2008 © Iris Pharma - Création CKC-Net.com Creation site Internet Cannes






